Abbar M
Service de Psychiatrie A, CHU Caremeau, Nîmes.
Encephale. 1996 Dec;22 Spec No 5:13-8.
Panic disorder first appeared as a specific diagnostic entity in 1980, in the third Edition of "Diagnostic and Statistical Manual of Mental Disorders" (DSM III). The classical anxiety neurosis was divided into two separate entities: panic disorder and generalized anxiety disorder, whose major criteria for distinction was based, in a simplified manner, on the presence or absence of panic attacks in the patient's history. Validity of the concept of panic disorder as a clinical and autonomous entity is now widely accepted. It is based on numerous epidemiological, phenomenological, biological, genetic and therapeutic studies that have established, that panic disorder may be clearly distinguished from other anxiety and mood disorders. However, this disorder still has unknown aetiology and criteria for definition remain purely clinical. Controversies as regards the validity of diagnostic criteria for panic disorders may account for its successive definitions in the DSM III-R, then in the DSM IV. In fact, in contrast to the definition of panic attacks that has remained practically constant, panic disorder was initially defined by the recurrence of panic attacks. It is now considered by the authors of the DSM IV as a disorder characterized by a chronic anxiety, focused on the risk for panic attacks showing symptoms evocative of autonomic dysregulation. In the DSM IV, panic attack is now considered as a syndrome which is not specific for panic disorder. Panic disorder may be diagnosed in a patient who has suffered from recurrent panic attacks, provided that one at least of the latter have been associated with one of the following symptoms: persisting fear from other panic attacks; concerns about possible implications of panic attacks or their consequences; major behavioural changes related to the attacks. Evolving positions of the successive authors of the DSM contrast with more conservative attitudes of the authors of the CIM 10, who still consider agoraphobia as a key symptom. Whatever the issues of these definitions, it must be kept in mind that panic disorder is a severe syndrome, and leads to major suffering and significant impairment of the patients' quality of life as well as their social life and interpersonal relationships. Comorbidity with depressive and addictive disorders is frequent, and panic disorder is considered by numerous authors as a risk factor for suicide. Due to the severity of panic disorder, its frequency and the fact that it is too often undiagnosed (although there are effective therapeutic strategies), efforts are fully warranted, so that patients may benefit from early diagnosis and adequate treatment.
惊恐障碍于1980年在《精神疾病诊断与统计手册》第三版(DSM-III)中首次作为一种特定的诊断实体出现。经典的焦虑神经症被分为两个独立的实体:惊恐障碍和广泛性焦虑障碍,其主要区分标准以简化的方式基于患者病史中是否存在惊恐发作。惊恐障碍作为一种临床独立实体概念的有效性现在已被广泛接受。它基于众多的流行病学、现象学、生物学、遗传学和治疗学研究,这些研究已经确定,惊恐障碍可以与其他焦虑和情绪障碍明显区分开来。然而,这种疾病的病因仍然不明,定义标准仍然纯粹是临床性的。关于惊恐障碍诊断标准有效性的争议可能解释了它在DSM-III-R以及随后的DSM-IV中的相继定义。事实上,与几乎保持不变的惊恐发作定义不同,惊恐障碍最初是由惊恐发作的复发来定义的。现在DSM-IV的作者认为它是一种以慢性焦虑为特征的疾病,这种焦虑集中在惊恐发作的风险上,表现出自主神经功能失调的症状。在DSM-IV中,惊恐发作现在被认为是一种并非惊恐障碍所特有的综合征。如果患者经历过反复的惊恐发作,并且至少其中一次发作与以下症状之一相关,就可以诊断为惊恐障碍:对其他惊恐发作持续的恐惧;对惊恐发作可能产生的影响或后果的担忧;与发作相关的主要行为改变。DSM相继各版作者不断变化的立场与《国际疾病分类》第10版(ICD-10)作者更为保守的态度形成对比,后者仍然将广场恐惧症视为关键症状。无论这些定义存在什么问题,必须记住惊恐障碍是一种严重的综合征,会导致患者极大的痛苦以及其生活质量、社交生活和人际关系的显著受损。与抑郁和成瘾性障碍的共病很常见,许多作者认为惊恐障碍是自杀的一个危险因素。由于惊恐障碍的严重性、其发病率以及常常未被诊断的事实(尽管有有效的治疗策略),完全有必要做出努力,以便患者能够从早期诊断和适当治疗中获益。